JAZZ vs SPB · P/E 1988, rev $2.28B vs P/E 26, rev $2.81B
Jazz Pharmaceuticals PLC (JAZZ) versus Spectrum Brands Holdings Inc (SPB) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Spectrum Brands Holdings Inc (SPB) is a household & personal products company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SPB revenue for 2025-09-30 was $2.81B. Net income was $100.4M. SPB currently screens at market cap $1.36B and trailing P/E 26.1.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SPB currently screens at market cap $1.36B and trailing P/E 26.1.
Not investment advice. Open the JAZZ and SPB stock pages for the full models.
Not investment advice.